Michaël Duruisseaux, Benjamin Besse, Nicolas Girard, Eric Dansin, Sophie Cousin, Julien Mazières, Ludovic Doucet, Anne Madroszyk, Laurent Greillier, Charles Ricordel, Sarah Cavaillon, Celine Mascaux, Cécile Vicier, Diego Tosi, Sara Calattini, Verane Schwiertz, Sylvie Bin, Fabien Subtil, Benoît You, Thomas Pierret. "IMMUNORARE 5 : A national platform of 5 academic phase II trials coordinated by Lyon University Hospital to assess the safety and the efficacy of the immunotherapy with domvanalimab + zimberelimab combination in patients with advanced rare cancers—The B3 Thymomas and Thymic Carcinomas Cohort.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps8130